Main Topics

  • Novel therapeutic approaches to lipid disorders and cardiovascular disease
  • Lipids, obesity and diabetes
  • Lipid trafficking and cellular homeostasis
  • Cross-talk between lipid metabolism and immune response
  • Genetics of lipid metabolism and atherosclerosis
  • New aspects and pathways in atherosclerosis
  • Epidemiology of lipid-mediated diseases: risk factors, prevention and novel biomarkers

Program

Thursday, December 7, 2017

06:00 -
11:00 pm

Opening Ceremony, Lecture and Welcome Reception at the Salles de Pologne, Leipzig

 

 

Friday, December 8, 2017

 

08:30 -
10:00 am
Plenary Session 1
Chairs: tba
Genetics of coronary artery disease: Progress in discovery and translation
Nilesh Samani (United Kingdom)
Triglycerides and remnant cholesterol in cardiovascular disease and pancreatitis
Børge Nordestgaard (Denmark)
Drugging Gut Microbial Enzymes as a Therapeutic Strategy in Cardiometabolic Disease
Mark J Brown (United States)
10:00 -
10:30 am
Coffee Break

10:30 am -
12:30 pm

WS1: Adipose Tissue and Lipid Biology

Chair: tba

WS2: Risk factors of CVD

Chair: tba

Dysfunctional adipose tissue in metabolic disease (working title)
Matthias Blüher (Germany)
The complexity of the regulation of Lp(a) concentrations: still good for a surprise
Florian Kronenberg (Austria)
Macrophages in adipose tissue
Triantafyllos Chavakis (Germany)
Proteomics, Lipidomics and MicroRNAs: From Molecules to Patients
Manuel Mayr (United Kingdom)
Autophagy in adipose tissue (working title)
Assaf Rudich (Israel)
Assessing cardiometabolic risk factors in the Central MRI trial (working title)
Iris Shai (Israel)
Talk(s) Chosen from Abstracts MONET-filtration is an effective alternative to ISIS 304801 Apo CIII antisense oligonucleotide therapy for the reduction of atherogenic Apo CIII-particles
Gerd Schmitz (Germany)
  Talk(s) Chosen from Abstracts
12:30 -
02:30 pm

Lunch Break

02:30 -
04:00 pm
Plenary Session 2
Chairs: tba

Mechanisms and Cardiometabolic Consequences of Fatty Liver
Jan Borén (Sweden)

Activation of macrophage inflammation and cell death in response to atherogenic lipids
Katey Rayner (Canada)
Regulation of lipid metabolism by Angiopietin-like proteins
Sander Kersten (The Netherlands)
04:00 -
04:30 pm
Coffee Break
04:30 -
05:50 pm
WS3: High-Density Lipoproteins
Chairs: tba
WS4: Linking metabolism and inflammation
Chairs: tba
Cellular interactions of HDL
Arnold von Eckardstein (Switzerland)
Metabolic regulation of T cell trafficking
Federica Marelli-Berg (United Kingdom)

tba
Jerzy Roch Nofer (Germany)

Inflammasome activation by ApoCIII
Ulrich Laufs (Germany)

HDL function in cardiovascular disease relation to inflammation
Ulf Landmesser (Germany)
Cholesterol Efflux Pathways Suppress Inflammasome Activation in Mice and Humans
Marit Westerterp (The Netherlands)
Talk(s) Chosen from Abstracts Talk(s) Chosen from Abstracts

 

 

Saturday, December 9, 2017

 

08:30 -
10:00 am
Poster Session & Breakfast
Chairs: tba
10:00 -
10:30 am
Coffee Break
10:30 am -
12:30 pm
Plenary Session 3
Chairs: tba
Circadian control of inflammation through nuclear receptor signaling
Bart Staels (France)
Immune regulation of lipid metabolism (working title)
Anthony Ferrante (United States)

Macrophages in many guises in atherosclerosis
Edward A. Fischer (United States)

Chemokines in atherosclerosis
Christian Weber (Germany)
12:30 -
01:30 pm
Lunch Break
01:30 -
02:50 pm
WS 5: Mechanisms and Modulators of atherosclerosis
Chairs: tba
WS 6: Genetic and Genomic Studies
Chairs: tba
Immune Checkpoint Regulators in Atherosclerosis
Esther Lutgens (The Netherlands)
Genetic and non-genetic factors influencing PCSK9 plasma levels and its relations to vascular phenotypes
Markus Scholz (Germany)
tbd Circular RNAs in Atherosclerosis (working title)
Lesca Miriam Holdt (Germany)
tbd
Ralph Burkhardt (Germany)
tbd
Daniel Teupser (Germany)
Talk(s) Chosen from Abstracts Talk(s) Chosen from Abstracts